NNovo Nordisk Read More Novo Nordisk’s Oral Ozempic Arrives as GLP-1 Data Opens New Frontier2026-05-03 Novo Nordisk enters a critical week with US launch of improved oral Ozempic, Lancet study showing semaglutide cuts…